ID   LHK2
AC   CVCL_D228
SY   LHK-2
DR   Wikidata; Q54902471
RX   PubMed=12060610;
RX   PubMed=19818766;
CC   Population: Japanese.
CC   HLA typing: A*02:07,24:02; B*46:01,48:01; C*01:02 (PubMed=19818766).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
RX   PubMed=12060610;
RA   Hirohashi Y., Torigoe T., Maeda A., Nabeta Y., Kamiguchi K., Sato T.,
RA   Yoda J., Ikeda H., Hirata K., Yamanaka N., Sato N.;
RT   "An HLA-A24-restricted cytotoxic T lymphocyte epitope of a
RT   tumor-associated protein, survivin.";
RL   Clin. Cancer Res. 8:1731-1739(2002).
//
RX   PubMed=19818766; DOI=10.1016/j.yexmp.2009.09.021;
RA   Hirohashi Y., Torigoe T., Hirai I., Tamura Y., Nakatsugawa M.,
RA   Inoue Y., Kanaseki T., Kamiguchi K., Ikeda H., Sasaki A., Yamanaka N.,
RA   Sato N.;
RT   "Establishment of shared antigen reactive cytotoxic T lymphocyte using
RT   co-stimulatory molecule introduced autologous cancer cells.";
RL   Exp. Mol. Pathol. 88:128-132(2010).
//